Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of SLC16A14 mRNA | CTD | PMID:23649840 | 17beta-estradiol | decreases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | Estradiol results in decreased expression of SLC16A14 mRNA | CTD | PMID:19484750 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC16A14 mRNA | CTD | PMID:31614463 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC16A14 mRNA | CTD | PMID:30165855 | 17beta-estradiol | multiple interactions | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of SLC16A14 mRNA | CTD | PMID:26496021 | 2,2',5,5'-tetrachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc16a14 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC16A14 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC16A14 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC16A14 mRNA | CTD | PMID:27913140 | 3-chloropropane-1,2-diol | increases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of SLC16A14 mRNA | CTD | PMID:28522335 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of SLC16A14 mRNA | CTD | PMID:33297965 | 6-propyl-2-thiouracil | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of SLC16A14 mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of SLC16A14 intron | CTD | PMID:30157460 | aldehydo-D-glucose | multiple interactions | ISO | Slc16a14 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA | CTD | PMID:37567420 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SLC16A14 mRNA | CTD | PMID:33167477 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of SLC16A14 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of SLC16A14 gene | CTD | PMID:25304211 | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA | CTD | PMID:27188386 | belinostat | decreases expression | EXP | | 6480464 | belinostat results in decreased expression of SLC16A14 mRNA | CTD | PMID:26272509 | benzo[a]pyrene | increases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC16A14 mRNA | CTD | PMID:23735875 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of SLC16A14 mRNA | CTD | PMID:31163220 | bisphenol A | multiple interactions | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of SLC16A14 mRNA | CTD | PMID:26496021 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC16A14 mRNA | CTD | PMID:29275510 | bisphenol A | increases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLC16A14 mRNA | CTD | PMID:30816183 | bisphenol A | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC16A14 mRNA | CTD | PMID:25181051 | butan-1-ol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC16A14 mRNA | CTD | PMID:29432896 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of SLC16A14 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SLC16A14 mRNA | CTD | PMID:21592394 | cefaloridine | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Cephaloridine results in decreased expression of SLC16A14 mRNA | CTD | PMID:18500788 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC16A14 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SLC16A14 mRNA | CTD | PMID:34289071 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC16A14 mRNA | CTD | PMID:20971185 | copper atom | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Copper results in decreased expression of SLC16A14 mRNA | CTD | PMID:30556269 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SLC16A14 mRNA | CTD | PMID:20971185 | copper(0) | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Copper results in decreased expression of SLC16A14 mRNA | CTD | PMID:30556269 | Cuprizon | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of SLC16A14 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of SLC16A14 mRNA | CTD | PMID:27989131 | D-glucose | multiple interactions | ISO | Slc16a14 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA | CTD | PMID:37567420 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | increases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of SLC16A14 mRNA | CTD | PMID:29391264 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of SLC16A14 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA | CTD | PMID:27188386 | ethanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SLC16A14 mRNA | CTD | PMID:29432896 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SLC16A14 mRNA | CTD | PMID:31059573 | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of SLC16A14 mRNA | CTD | PMID:23649840 | fenfluramine | decreases expression | EXP | | 6480464 | Fenfluramine results in decreased expression of SLC16A14 mRNA | CTD | PMID:22140631 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of SLC16A14 mRNA | CTD | PMID:23649840 | fructose | multiple interactions | ISO | Slc16a14 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA | CTD | PMID:37567420 | glucose | multiple interactions | ISO | Slc16a14 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC16A14 mRNA | CTD | PMID:37567420 | GW 4064 | decreases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | GW 4064 results in decreased expression of SLC16A14 mRNA | CTD | PMID:26655953 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of SLC16A14 mRNA | CTD | PMID:28988120 | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of SLC16A14 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC16A14 mRNA | CTD | PMID:35811015 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of SLC16A14 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of SLC16A14 mRNA | CTD | PMID:28001369 | N-methyl-4-phenylpyridinium | increases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SLC16A14 mRNA | CTD | PMID:24810058 | N-methyl-4-phenylpyridinium | increases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SLC16A14 mRNA | CTD | PMID:28801915 | niclosamide | increases expression | EXP | | 6480464 | Niclosamide results in increased expression of SLC16A14 mRNA | CTD | PMID:36318118 | ochratoxin A | decreases methylation | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | ochratoxin A results in decreased methylation of SLC16A14 gene | CTD | PMID:26431795 | orphenadrine | affects expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Orphenadrine affects the expression of SLC16A14 mRNA | CTD | PMID:23665939 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC16A14 mRNA | CTD | PMID:35430440 | ozone | decreases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | Ozone results in decreased expression of SLC16A14 mRNA | CTD | PMID:33026818 | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | EXP | | 6480464 | panobinostat results in decreased expression of SLC16A14 mRNA | CTD | PMID:26272509 | paracetamol | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SLC16A14 mRNA | CTD | PMID:30723492 | paracetamol | increases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SLC16A14 mRNA | CTD | PMID:33387578 | paraquat | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of SLC16A14 mRNA | CTD | PMID:32680482 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of SLC16A14 mRNA | CTD | PMID:22714537 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SLC16A14 mRNA | CTD | PMID:29955902 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC16A14 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SLC16A14 mRNA | CTD | PMID:34032870 | sulforaphane | increases expression | EXP | | 6480464 | sulforaphane results in increased expression of SLC16A14 mRNA | CTD | PMID:31838189 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SLC16A14 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of SLC16A14 mRNA | CTD | PMID:31758290 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of SLC16A14 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of SLC16A14 mRNA | CTD | PMID:21592394 | thimerosal | increases expression | EXP | | 6480464 | Thimerosal results in increased expression of SLC16A14 mRNA | CTD | PMID:27188386 | titanium dioxide | decreases expression | ISO | Slc16a14 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SLC16A14 mRNA | CTD | PMID:29264374 | trichloroethene | increases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of SLC16A14 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of SLC16A14 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC16A14 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of SLC16A14 mRNA | CTD | PMID:24935251 and PMID:26272509 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SLC16A14 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SLC16A14 mRNA | CTD | PMID:23179753 more ... | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLC16A14 mRNA | CTD | PMID:24935251 | vinclozolin | decreases expression | ISO | Slc16a14 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of SLC16A14 mRNA | CTD | PMID:23869203 | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of SLC16A14 mRNA | CTD | PMID:23649840 | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of SLC16A14 mRNA | CTD | PMID:24714768 | |